• Explore /
  • Poster
  • / Sperm associated antigen 5 (SPAG5) as a predictor and monitor for response and distant relapse risk (DRR) to endocrine (ET) and chemo-therapies (CT) in oestrogen receptor positive (ER+) breast cancer (BC).

Sperm associated antigen 5 (SPAG5) as a predictor and monitor for response and distant relapse risk (DRR) to endocrine (ET) and chemo-therapies (CT) in oestrogen receptor positive (ER+) breast cancer (BC).

Abstract Poster

Authors

null

Tarek Mohamed Ahmed Abdel-Fatah

Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

Tarek Mohamed Ahmed Abdel-Fatah , Graham Ball , Amy McCart Reid , Peter Simpson , Sunil R. Lakhani , Lorinc Pongor , Balazs Gyorffy , Paul M Moseley , Andrew R. Green , A. Graham Pockley , Carlos Caldas , Ian O. Ellis , Stephen Chan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Hormone Receptor-Positive

Citation

J Clin Oncol 36, 2018 (suppl; abstr 1066)

DOI

10.1200/JCO.2018.36.15_suppl.1066

Abstract #

1066

Poster Bd #

147

Abstract Disclosures

Similar Posters

First Author: Steven Allen Buechler

First Author: Tarek Mohamed Ahmed Abdel-Fatah

First Author: Aleix Prat

First Author: Tarek M. A. Abdel-Fatah